[1]
|
Hevia A, Milani C, López P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus[J]. mBio, 2014, 5: e01548-14. |
[2]
|
He Z, Shao T, Li H, et al. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus[J]. Gut Pathog, 2016, 8: 64. doi: 10.1186/s13099-016-0146-9 |
[3]
|
Chen BD, Jia XM, Xu JY, et al. An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus[J]. Arthritis Rheumatol, 2021, 73: 232-243. |
[4]
|
Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal[J]. Ann Rheum Dis, 2019, 78: 947-956. doi: 10.1136/annrheumdis-2018-214856 |
[5]
|
Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis[J]. Elife, 2013, 2: e01202. doi: 10.7554/eLife.01202 |
[6]
|
Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment[J]. Nat Med, 2015, 21: 895-905. doi: 10.1038/nm.3914 |
[7]
|
Tang R, Wei Y, Li Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J]. Gut, 2018, 67: 534-541. doi: 10.1136/gutjnl-2016-313332 |
[8]
|
Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. doi: 10.1136/annrheumdis-2016-211064 |
[9]
|
Mandl T, Marsal J, Olsson P, et al. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity[J]. Arthritis Res Ther, 2017, 19: 237. doi: 10.1186/s13075-017-1446-2 |
[10]
|
Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, et al. Connection between the Gut Microbiome, Systemic Inflammation, Gut Permeability and FOXP3 Expression in Patients with Primary Sjögren's Syndrome[J]. Int J Mol Sci, 2020, 21: 8733. doi: 10.3390/ijms21228733 |
[11]
|
Zhou C, Zhao H, Xiao XY, et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis[J]. J Autoimmun, 2020, 107: 102360. doi: 10.1016/j.jaut.2019.102360 |
[12]
|
Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. doi: 10.1136/annrheumdis-2016-211064 |
[13]
|
Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients[J]. Genome Med, 2017, 9: 103. doi: 10.1186/s13073-017-0490-5 |
[14]
|
Gomez-Banuelos E, Mukherjee A, Darrah E, et al. Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans[J]. J Clin Med, 2019, 8: 1309. doi: 10.3390/jcm8091309 |
[15]
|
Bagavant H, Dunkleberger ML, Wolska N, et al. Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients[J]. Clin Exp Rheumatol, 2019, 37: 106-111. |
[16]
|
Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans[J]. Science, 2018, 359: 1156-1161. doi: 10.1126/science.aar7201 |
[17]
|
Zegarra-Ruiz DF, El Beidaq A, Iniguez AJ, et al. A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity[J]. Cell Host Microbe, 2019, 25: 113-127. e6. doi: 10.1016/j.chom.2018.11.009 |
[18]
|
Ruff WE, Dehner C, Kim WJ, et al. Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity[J]. Cell Host Microbe, 2019, 26: 100-113. e8. doi: 10.1016/j.chom.2019.05.003 |
[19]
|
Greiling TM, Dehner C, Chen X, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus[J]. Sci Transl Med, 2018, 10: eaan2306. doi: 10.1126/scitranslmed.aan2306 |
[20]
|
Szymula A, Rosenthal J, Szczerba BM, et al. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria[J]. Clin Immunol, 2014, 152: 1-9. doi: 10.1016/j.clim.2014.02.004 |
[21]
|
Zhang L, Zhang YJ, Chen J, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review[J]. Microb Pathog, 2018, 117: 49-54. doi: 10.1016/j.micpath.2018.02.020 |
[22]
|
Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells[J]. Nature, 2013, 504: 446-450. doi: 10.1038/nature12721 |
[23]
|
Sivaprakasam S, Prasad PD, Singh N. Benefits of Short-chain fatty acids and their receptors in inflammation and carcinogenesis[J]. Pharmacol Ther, 2016, 164: 144-151. doi: 10.1016/j.pharmthera.2016.04.007 |
[24]
|
Rosser EC, Piper CJM, Matei DE, et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells[J]. Cell Metab, 2020, 31: 837-851. e10. doi: 10.1016/j.cmet.2020.03.003 |
[25]
|
Sanchez HN, Moroney JB, Gan H, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids[J]. Nat Commun, 2020, 11: 60. doi: 10.1038/s41467-019-13603-6 |
[26]
|
Kidd BA, Ho PP, Sharpe O, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination[J]. Arthritis Res Ther, 2008, 10: R119. doi: 10.1186/ar2523 |
[27]
|
Bagavant H, Araszkiewicz AM, Ingram JK, et al. Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies[J]. Front Immunol, 2021, 12: 635072. doi: 10.3389/fimmu.2021.635072 |
[28]
|
Hsu TC, Huang CY, Liu CH, et al. Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice[J]. Br J Nutr, 2017, 117: 1066-1074. doi: 10.1017/S0007114517001039 |
[29]
|
Yeh YL, Lu MC, Tsai BC, et al. Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice[J]. Probiotics Antimicrob Proteins, 2021, 13: 51-59. doi: 10.1007/s12602-020-09668-1 |
[30]
|
Tzang BS, Liu CH, Hsu KC, et al. Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice[J]. Br J Nutr, 2017, 118: 333-342. doi: 10.1017/S0007114517002112 |
[31]
|
Li Y, Wang HF, Li X, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus[J]. Clin Sci (Lond), 2019, 133: 821-838. doi: 10.1042/CS20180841 |
[32]
|
Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science, 2018, 359: 91-97. doi: 10.1126/science.aan3706 |
[33]
|
Artacho A, Isaac S, Nayak R, et al. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis[J]. Arthritis Rheumatol, 2021, 73: 931-942. doi: 10.1002/art.41622 |
[34]
|
Nayak RR, Alexander M, Deshpande I, et al. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation[J]. Cell Host Microbe, 2021, 29: 362-377. e11. doi: 10.1016/j.chom.2020.12.008 |
[35]
|
Zaragoza-Garcia O, Castro-Alarcon N, Perez-Rubio G, et al. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy[J]. Biomolecules, 2020, 10: 1479. doi: 10.3390/biom10111479 |
[36]
|
Araya RE, Goldszmid RS. Two Bugs a NOD Away from Improving Cancer Therapy Efficacy[J]. Immunity, 2016, 45: 714-716. doi: 10.1016/j.immuni.2016.10.007 |
[37]
|
Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis[J]. Genome Med, 2016, 8: 43. doi: 10.1186/s13073-016-0299-7 |
[38]
|
Flannigan KL, Taylor MR, Pereira SK, et al. An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil[J]. J Heart Lung Transplant, 2018, 37: 1047-1059. doi: 10.1016/j.healun.2018.05.002 |
[39]
|
Taylor MR, Flannigan KL, Rahim H, et al. Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial beta-glucuronidase activity[J]. Sci Adv, 2019, 5: eaax2358. doi: 10.1126/sciadv.aax2358 |
[40]
|
Kim DS, Park Y, Choi JW, et al. Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway[J]. Front Immunol, 2021, 12: 696074. doi: 10.3389/fimmu.2021.696074 |
[41]
|
Furukawa M, Moriya K, Nakayama J, et al. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis[J]. Hepatol Res, 2020, 50: 840-852. doi: 10.1111/hepr.13509 |
[42]
|
Bazin T, Hooks KB, Barnetche T, et al. Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study[J]. Sci Rep, 2018, 8: 5446. doi: 10.1038/s41598-018-23571-4 |
[43]
|
Yin J, Sternes PR, Wang M, et al. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition[J]. Ann Rheum Dis, 2020, 79: 132-140. doi: 10.1136/annrheumdis-2019-215763 |
[44]
|
Zhou Y, Xu ZZ, He Y, et al. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction[J]. mSystems, 2018, 3: e00188-17. |
[45]
|
Aden K, Rehman A, Waschina S, et al. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases[J]. Gastroenterology, 2019, 157: 1279-1292. e11. doi: 10.1053/j.gastro.2019.07.025 |
[46]
|
Pan H, Guo R, Ju Y, et al. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis[J]. Microbiome, 2019, 7: 107. doi: 10.1186/s40168-019-0719-1 |
[47]
|
Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial[J]. Int J Rheum Dis, 2016, 19: 869-879. doi: 10.1111/1756-185X.12888 |
[48]
|
Alpizar-Rodriguez D, Lesker TR, Gronow A, et al. Prevo-tella copri in individuals at risk for rheumatoid arthritis[J]. Ann Rheum Dis, 2019, 78: 590-593. doi: 10.1136/annrheumdis-2018-214514 |
[49]
|
Marietta EV, Murray JA, Luckey DH, et al. Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice[J]. Arthritis Rheumatol, 2016, 68: 2878-2888. doi: 10.1002/art.39785 |
[50]
|
Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial[J]. BMC Complement Altern Med, 2010, 10: 1. doi: 10.1186/1472-6882-10-1 |
[51]
|
Shokryazdan P, Faseleh Jahromi M, Navidshad B, et al. Effects of prebiotics on immune system and cytokine expression[J]. Med Microbiol Immunol, 2017, 206: 1-9. doi: 10.1007/s00430-016-0481-y |
[52]
|
Wilson B, Eyice O, Koumoutsos I, et al. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms[J]. Nutrients, 2021, 13: 3598. doi: 10.3390/nu13103598 |
[53]
|
Ho J, Nicolucci AC, Virtanen H, et al. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes[J]. J Clin Endocrinol Metab, 2019, 104: 4427-4440. doi: 10.1210/jc.2019-00481 |
[54]
|
Moro G, Arslanoglu S, Stahl B, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age[J]. Arch Dis Child, 2006, 91: 814-819. doi: 10.1136/adc.2006.098251 |
[55]
|
Zeng J, Peng L, Zheng W, et al. Fecal microbiota transplantation for rheumatoid arthritis: A case report[J]. Clin Case Rep, 2020, 9: 906-909. |
[56]
|
Kragsnaes MS, Kjeldsen J, Horn HC, et al. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial[J]. BMJ Open, 2018, 8: e019231. doi: 10.1136/bmjopen-2017-019231 |
[57]
|
Picchianti Diamanti A, Panebianco C, Salerno G, et al. Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients[J]. Microorganisms, 2020, 8: 1989. doi: 10.3390/microorganisms8121989 |
[58]
|
Gutierrez-Diaz I, Fernandez-Navarro T, Sanchez B, et al. Mediterranean diet and faecal microbiota: a transversal study[J]. Food Funct, 2016, 7: 2347-2356. doi: 10.1039/C6FO00105J |
[59]
|
Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal modulates TH17 axis and disease[J]. Nature, 2017, 551: 585-589. doi: 10.1038/nature24628 |
[60]
|
Zhang H, Liao X, Sparks JB, et al. Dynamics of gut microbiota in autoimmune lupus[J]. Appl Environ Microbiol, 2014, 80: 7551-7560. doi: 10.1128/AEM.02676-14 |